TSXV:MBI.H - Post by User
Comment by
slagheapon Aug 22, 2014 1:58pm
154 Views
Post# 22869984
RE:RE:RE:This Story Gets....
RE:RE:RE:This Story Gets.... Med BioGene Files for US IPO
December 30, 2009
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Canadian personalized diagnostics firm Med BioGene has filed for an initial public offering in the US.
The Vancouver-based firm, which trades on the Toronto Stock Exchange, did not say how much it expects to raise in proceeds from the offering. Though the preliminary prospectus also did not provide the price for the common shares being offered in the US, the firm noted that its shares closed Dec. 24 on the TSX at C$6 (US$5.66) — after giving effect to an assumed 1-for-50 reverse stock split of its outstanding common shares that it expects to effect prior to or upon the date of the offering.
Med BioGene has developed LungExpress Dx, a 15-gene signature test for use in identifying those patients with early-stage non-small-cell lung cancer, who are at a higher or lower risk of mortality following surgical removal of their tumor. The firm expects to launch the test in the US during 2010.